These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 12472943

  • 21. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.
    Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, de la Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W.
    Hepatology; 2016 Jan; 63(1):207-16. PubMed ID: 26403564
    [Abstract] [Full Text] [Related]

  • 22. [Edema in liver disease].
    Maekawa H, Toda G.
    Nihon Rinsho; 2005 Jan; 63(1):80-4. PubMed ID: 15675322
    [Abstract] [Full Text] [Related]

  • 23. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J.
    Hepatology; 1988 Jan; 8(5):1151-7. PubMed ID: 2971015
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J, Zhang L, Han GH, Fan DM.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct 20; 24(10):721-723. PubMed ID: 27938554
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hyponatremia in cirrhosis: pathophysiology and management.
    John S, Thuluvath PJ.
    World J Gastroenterol; 2015 Mar 21; 21(11):3197-205. PubMed ID: 25805925
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The pathophysiology of ascites formation in cirrhosis of the liver].
    Benjaminov FS.
    Harefuah; 2002 Aug 21; 141(8):721-5, 760. PubMed ID: 12222138
    [Abstract] [Full Text] [Related]

  • 32. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA, Díez J, Prieto J.
    Gastroenterology; 1991 Nov 21; 101(5):1354-60. PubMed ID: 1936807
    [Abstract] [Full Text] [Related]

  • 33. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC, Vaillant JC, Breton S, Hannoun L.
    Ann Chir; 1999 Nov 21; 53(10):966-72. PubMed ID: 10670142
    [Abstract] [Full Text] [Related]

  • 34. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E, Cardenas A.
    Dig Dis; 2017 Nov 21; 35(4):402-410. PubMed ID: 28468013
    [Abstract] [Full Text] [Related]

  • 35. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb 21; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 36. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis.
    Cárdenas A, Ginès P.
    Semin Nephrol; 2001 May 21; 21(3):308-16. PubMed ID: 11320500
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of refractory ascites].
    Martínez J, Albillos A.
    Gastroenterol Hepatol; 2014 Jul 21; 37 Suppl 2():68-73. PubMed ID: 25087715
    [Abstract] [Full Text] [Related]

  • 38. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G.
    Gastroenterologist; 1995 Mar 21; 3(1):41-54. PubMed ID: 7743121
    [Abstract] [Full Text] [Related]

  • 39. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J, Iwakiri Y.
    Hepatol Int; 2018 Feb 21; 12(Suppl 1):1-10. PubMed ID: 29064029
    [Abstract] [Full Text] [Related]

  • 40. Portal hypertension.
    Garcia-Tsao G.
    Curr Opin Gastroenterol; 2006 May 21; 22(3):254-62. PubMed ID: 16550040
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.